NWBO would be rejected as FDA told them not to bother filing after they reviewed the P3 trial. NWBO violated a series of FDA guidelines and FDA told them they wouldn't accept an commercial application which is why NWBO had to resort to filing in UK with MHRA.
Market Data 
Markets 
AI
